UnitedHealth stock dropped 33% amid fraud concerns, CEO resignation, and suspended 2025 guidance. Read why UNH continues to ...

Gold futures posted their worst weekly showing in nearly four years, as the U.S.-China tariff de-escalation removed some ...

Discover why Artisan Partners Asset Management Inc. is poised to outperform. Click for my review of APAM's latest earnings ...

Under Armour faces declining revenue, weak DTC and footwear sales, and tariff uncertainties, complicating its turnaround ...

Schwab U.S. Dividend Equity remains a conservative, diversified choice for stable, reliable, and growing dividends. Click for ...

Large-cap growth led in 2023 and 2024, thanks to the two years of +25% returns for the SP 500, but the value style held in ...

Bayer A.G.'s stock is undervalued but faces risks with declining profits & regulatory pressures. Click for my updated look at ...

Zepbound outperformed Nordisk's Wegovy in terms of weight loss, solidifying Lilly's leadership in the anti-obesity drug ...

Explore Leonardo S.p.a.'s 100% stock surge amid Europe's defense focus. Click for my updated look at FINMY stock post Q1 ...

With the premium down 10% from the high, I am willing to give GOF a cautious buy rating again. Read to know why GOF may be a ...

The company lacks pricing power and is heavily dependent on paid advertising, with thin operating margins and no clear ...

Dutch Bros plans to double stores by 2029, driving growth despite modest same-store sales. Overvalued stock suggests a 'hold' ...